SOUTH SAN FRANCISCO, Calif., April 24, 2013 /PRNewswire/ --KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company has been selected to present at the 12th Annual Needham Healthcare Conference, to be held in New York City on April 30-May 1, 2013. KaloBios Chief Financial Officer, Jeffrey H. Cooper, will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.
Company Presentation: When: Tuesday, April 30, 2013, 9:20 am EDT, Ambassador Presentation Room Where: The Westin Grand Central Hotel, New York, NY
Webcast: To access the live and archived audio webcast of the Needham Healthcare Conference presentation please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: http://ir.kalobios.com/events.cfm.
A replay of the webcast will be available one hour after the conclusion of the live event.
KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat serious medical conditions with a primary clinical focus on respiratory diseases and cancer. For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.
Jeffrey H. Cooper Chief Financial Officer KaloBios Pharmaceuticals, Inc. (650) 243-3146 [email protected]
Joan E. Kureczka Kureczka/Martin Associates Tel: (415) 821-2413 Mobile: (415) 690-0210 [email protected]